Clarivate Director Cornick Buys 900,000 Shares for $1.7 Million. What Does This Tell Investors About the Outlook for 2026?
Clarivate Director Kenneth L. Cornick recently purchased 900,000 shares of Clarivate Plc (NYSE:CLVT) for $1.7 million, increasing his total holdings by 74%. This significant insider purchase suggests a bullish outlook despite the stock's 52% decline over the past year and analyst predictions of declining sales. Management anticipates modest growth of about 2% for 2026 after selling non-core divisions, a strategy Cornick seems to endorse.
AI in healthcare: Are you tracking the right competitors?
This article discusses how patent intelligence can reveal unexpected competitors in the rapidly evolving field of AI in healthcare. It highlights that medical technology companies are leading in AI-related patent filings, and relevant AI capabilities are emerging from diverse industries such as computing and digital platforms, not just traditional life sciences. The author suggests that IP teams should track technologies across industry boundaries to identify potential partners, acquisition targets, or competitive threats early on.
CLVT|Clarivate PLC|Price:1.923|Chg%:-0.037
This article provides a detailed overview of Clarivate PLC (CLVT) stock, including its current price, market capitalization, key financial figures, and recent performance. It also covers analyst ratings, a technical analysis summary, company profile, and major shareholders. The stock's current rating is "Hold" with a target price indicating a significant upside potential.
ETFs Investing in Clarivate PLC Stocks
This article lists various Exchange Traded Funds (ETFs) that hold Clarivate PLC (16A) stocks, providing investors with options to invest in the company indirectly. Each ETF entry includes details such as market value, weight of Clarivate PLC in the fund, issuer, management style, focus, expense ratio, assets under management (AUM), price, and 3-year NAV total return. The ETFs predominantly focus on small-cap, value, and extended market strategies.
Does Clarivate’s Expanded Agentic AI Across Cortellis Reshape the Bull Case For Clarivate (CLVT)?
Clarivate Plc has expanded agentic AI capabilities across its Cortellis life sciences portfolio, aiming to integrate AI into drug discovery, safety assessment, and portfolio decision workflows. This move seeks to reduce manual effort and support faster, evidence-based decisions, reinforcing Clarivate's investment narrative around workflow integration and efficiency. While this could enhance the bull case, investors should remain aware of potential risks such as competition, pricing pressure, continued net losses, and the company's high debt load.
Is Clarivate (CLVT) Below Fair Value On Its Cortellis Agentic AI Expansion?
Clarivate (CLVT) has expanded its Cortellis portfolio with new agentic AI capabilities aimed at accelerating life sciences R&D, despite its stock experiencing a significant decline. The company's valuation narrative suggests it is undervalued at $2.50 per share compared to its current price of $1.91, emphasizing recurring revenue and future profit potential. However, concerns about higher education budgets and competition from free research data could impact its growth.
Clarivate : and KYBORA Partner to Help Biopharma Companies Execute Strategic Transaction Outcomes
Clarivate and KYBORA have partnered to offer integrated, end-to-end transaction advisory services for bioph
Does Clarivate’s Expanded Agentic AI Across Cortellis Reshape the Bull Case For Clarivate (CLVT)?
Clarivate Plc has expanded its agentic AI capabilities across its Cortellis life sciences portfolio to integrate AI into drug discovery, safety assessment, and portfolio decision workflows. This move aims to reduce manual effort and support faster, evidence-based decisions, reinforcing Clarivate's investment narrative around workflow integration and efficiency. While the AI expansion supports deeper workflow integration, investors should also consider risks such as competition, pricing pressure, continued net losses, and the company's high debt load.
Clarivate (NYSE:CLVT) Shares Gap Up on Insider Buying Activity
Clarivate (NYSE:CLVT) shares gapped up after Director Kenneth L. Cornick purchased 900,000 shares across two transactions totaling approximately $1.67 million. This insider buying activity occurred despite cautious analyst sentiment, with a consensus "Reduce" rating and a price target of $3.02. The company slightly exceeded EPS estimates but reported a 5.5% year-over-year revenue decline.
Clarivate PLC (16A.MU) Analyst Insights, Price Targets & Recommendations
This article provides analyst ratings and price targets for Clarivate PLC (16A.MU). It lists recent "Upgrades & Downgrades" showing various firms maintaining their ratings, including Citigroup, Goldman Sachs, Stifel, and Barclays, with the latest update on July 30, 2026. The stock's current price is 1.6740 EUR.
Kenneth Cornick Acquires 650,000 Shares of Clarivate (NYSE:CLVT) Stock
Clarivate director Kenneth Cornick recently acquired 650,000 shares of NYSE:CLVT stock for approximately $1.21 million, significantly increasing his direct ownership by 59.09% to 1.75 million shares. Despite Clarivate's shares rising 4.4% to $1.90, they remain near their one-year low, and analysts maintain a cautious "Reduce" rating with a $3.02 target price. The company reported a Q2 EPS of $0.19, beating estimates, though revenue declined by 5.5% year-over-year.
Clarivate (NYSE:CLVT) Director Kenneth Cornick Buys 250,000 Shares of Stock
Clarivate (NYSE:CLVT) Director Kenneth Cornick purchased 250,000 shares of the company's stock on August 7th, investing $462,500 at an average price of $1.85 per share. This transaction increased his direct ownership to 2 million shares, a 14.29% increase. Despite the insider buying, analyst sentiment remains cautious, with a consensus "Reduce" rating and a target price of $3.02, following a recent earnings report that showed a 5.5% year-over-year revenue decline.
Enterprise value to EBIT forward of Clarivate Plc – NYSE:CLVT
The article focuses on the enterprise value to EBIT forward for Clarivate Plc (NYSE: CLVT). It presents financial data within the TradingView platform context, highlighting the company's stock information and financial metrics. The primary content available is a data point for this specific financial ratio.
Knowledge graphs: Turning fragmented biomedical data into connected, actionable insight
This article discusses how knowledge graphs address the challenge of fragmented biomedical data, transforming it into actionable insights. It highlights that the problem is not data abundance but usability, with knowledge graphs connecting disparate data points into a unified framework. The piece also explains how Clarivate's AI-powered knowledge graphs are built with trusted data to drive impact across the R&D continuum and make complex information accessible through AI agents.
Clarivate Plc (CLVT) Stock Forecasts
Clarivate Plc (CLVT) is a data, information, and software workflow solutions company, primarily serving academia, government, law, life sciences, and healthcare sectors. An analyst report from Morningstar on August 6, 2026, suggests that Clarivate is in the early stages of a multiyear turnaround. The company, formerly part of Thomson Reuters, was sold to private equity before becoming independent.
Clarivate Insider Sold Shares Worth $4,829,859, According to a Recent SEC Filing
An insider at Clarivate Plc reportedly sold shares valued at $4,829,859, as per a recent SEC filing. The article, published by MT Newswires, provides this financial transaction detail but restricts the full content to members. Clarivate Plc is a provider of transformative intelligence solutions across Academia & Government, Intellectual Property, and Life Sciences & Healthcare segments.
Andrew Miles Snyder Sells 2,489,618 Shares of Clarivate (NYSE:CLVT) Stock
Clarivate director Andrew Miles Snyder sold 2,489,618 shares of CLVT stock at an average price of $1.94, totaling approximately $4.83 million, reducing his direct ownership by 39.23%. This transaction occurred as Clarivate shares traded near their 52-week low and the company reported quarterly EPS of $0.19, slightly above expectations, despite a 5.5% year-over-year revenue decline. Analyst sentiment for Clarivate remains cautious, with a consensus "Reduce" rating, even though institutional investors hold a significant 85.72% of the stock.
Arrowstreet Capital Limited Partnership Acquires Shares of 1,320,982 Clarivate PLC $CLVT
Arrowstreet Capital Limited Partnership recently acquired 1,320,982 shares of Clarivate PLC (NYSE:CLVT) worth approximately $3.34 million, marking a new position and a 0.21% stake in the company. Despite Clarivate beating analyst EPS estimates with $0.19, its revenue of $587.3 million fell short of expectations and declined year-over-year. Institutional ownership stands at 85.72%, while analyst sentiment remains cautious, with a consensus "Reduce" rating and an average price target of $3.02, significantly higher than its recent trading price of $1.97.
Weekly Recap: Clarivate PLC Q2 2026 results and Michael Easton named CFO
Clarivate PLC (NYSE:CLVT) reported Q2 2026 results including $587.3M revenue, a GAAP loss of $268.6M, but adjusted net income of $123.1M and adjusted EBITDA of $247.2M. Michael Easton will become the new CFO on August 8, 2026, replacing Jonathan Collins. Following the results, Stifel lowered its price target for CLVT from $6.00 to $5.00.
Form 144 Clarivate Plc For: 3 August By Investing.com
This article from Investing.com reports the filing of Form 144 for Clarivate Plc on August 3rd. It briefly mentions Clarivate's stock symbol CLVT and its stock performance (+1.55%). The article also includes various market data like indices, commodities, and share prices, though these appear to be general market data rather than directly related to Clarivate's Form 144.
Clarivate (CLVT) plans potential NYSE sale of ProQuest merger consideration shares
Clarivate plc has filed a Form 144 notice indicating a potential sale of 2,489,618 ordinary shares on the NYSE through J.P. Morgan Securities LLC. These shares were originally acquired on December 1, 2021, as consideration for the merger of ProQuest LLC into Clarivate. The filing signals that these previously issued shares may now be sold on the open market.
Clarivate (NYSE:CLVT) Lowered to Hold Rating by Wall Street Zen
Wall Street Zen has downgraded Clarivate (NYSE:CLVT) from a "Buy" to a "Hold" rating. This move contributes to an overall bearish sentiment among analysts, with the stock currently holding a consensus "Reduce" rating and an average price target of $3.02. Clarivate's shares opened at $2.00, below key moving averages, and the company reported narrowly beating earnings expectations but missing revenue estimates with a 5.5% year-over-year decline.
First Trust Advisors LP Has $13.97 Million Stock Holdings in Clarivate PLC $CLVT
First Trust Advisors LP increased its stake in Clarivate PLC (NYSE:CLVT) by 10.3% in the first quarter, now holding 5,522,601 shares valued at $13.97 million. Other institutional investors like Royal Bank of Canada, AQR Capital Management LLC, Millennium Management LLC, Goldman Sachs Group Inc., and UBS AM also adjusted their positions in Clarivate. The company's recent earnings report showed mixed results with an EPS beat but a revenue miss, while analyst ratings are generally leaning towards "Reduce" with an average target price of $3.02.
Clarivate (NYSE:CLVT) Price Target Lowered to $5.00 at Stifel Nicolaus
Stifel Nicolaus has lowered its price target for Clarivate (NYSE:CLVT) from $6.00 to $5.00, while maintaining a "buy" rating, indicating a potential 149% upside from its current share price of $2.00. Despite beating EPS estimates, the company's Q2 revenue of $587.3 million missed expectations and declined 5.5% year-over-year, alongside a negative net margin. Clarivate's stock fell 6.7% to $2.00, and the broader analyst consensus currently rates it as "Reduce" with an average target of $3.23.
Clarivate PLC (NYSE:CLVT) Given Average Rating of "Reduce" by Brokerages
Clarivate PLC (NYSE:CLVT) has received a consensus "Reduce" rating from seven brokerages, with an average 12-month price target of $2.88. Despite slightly beating adjusted EPS estimates, the company's revenue declined 5.5% year-over-year and fell short of expectations, indicating ongoing profitability challenges. Several institutional investors have adjusted their holdings in Clarivate, and positive news includes reaffirming its 2026 financial outlook and strategic initiatives related to AI and divestitures, juxtaposed with negative sentiment around its revenue miss.
Clarivate (NYSE: CLVT) promotes Michael Easton to CFO role
Clarivate Plc announced the promotion of Michael Easton to Executive Vice President & Chief Financial Officer, effective August 8, 2026, following Jonathan Collins' resignation. Easton, previously Senior Vice President, Finance & Chief Accounting Officer, will receive a $600,000 base salary, 100% target annual bonus, and significant equity incentives. Concurrently, Matthew Lisowski was promoted to Senior Vice President, Chief Accounting Officer.
RiskMark wins Best AI Tool For Lawyers at the 2026 CODiE awards
RiskMark, an AI-powered trademark risk assessment solution by Clarivate, has won the Best AI Tool for Lawyers at the 2026 CODiE Awards, following its 2025 LegalTech Breakthrough Award. The platform helps legal professionals assess the likelihood of confusion, identify potential trademark conflicts, and develop stronger legal arguments using proprietary trademark data and legal precedent intelligence. RiskMark integrates predictive and generative AI, significantly reducing manual review time for trademark professionals.
Clarivate Releases Q2 2026 Financial Results
Clarivate Plc (CLVT) announced its Q2 2026 financial results, reporting an adjusted diluted EPS of $0.19, surpassing analyst estimates. The company generated $587.3M in revenue, a 5.5% year-over-year decrease, with organic ACV growth of 1.5%. Clarivate provided FY 2026 guidance, projecting adjusted EPS between $0.70 and $0.80 and revenue of $2.30B to $2.42B.
Clarivate PLC (CLVT) Q2 Earnings and Revenues Beat Estimates
Clarivate PLC (CLVT) reported strong Q2 results, with earnings of $0.19 per share surpassing the Zacks Consensus Estimate of $0.17 and revenues of $587.3 million beating expectations by 0.04%. Despite these beats and positive past performance in exceeding EPS estimates, Clarivate's stock has declined 28.1% year-to-date, contrasting with the S&P 500's gain, leading to a current Zacks Rank #3 (Hold) for the stock.
Clarivate appoints Michael Easton as chief financial officer
Clarivate Plc has appointed Michael Easton as its new Executive Vice President and Chief Financial Officer, effective August 8, 2026. Easton, who currently serves as Clarivate's Senior Vice President and Chief Accounting Officer, brings over 25 years of experience in finance. He will replace Jonathan Collins, who is stepping down to pursue other opportunities.
Clarivate PLC 2026: Revenue $587.3M, EPS ($0.42) — 10-Q Summary
Clarivate PLC reported its Q2 2026 results, showing a decline in revenue to $587.3M from $621.4M in the prior year, and an increased net loss resulting in an EPS of ($0.42) compared to ($0.11) previously. Key factors included product wind-downs, lower transactional activity, and migration from transactional to subscription sales, alongside a planned restructuring program and the sale of LS&H. Despite these changes, the company maintained a high annual customer renewal rate of 91.9%.
Clarivate Plc 2026 Q2 - Results - Earnings Call Presentation (NYSE:CLVT) 2026-07-29
Clarivate Plc (NYSE:CLVT) published its Q2 2026 earnings call presentation on July 29, 2026. The company reported an EPS of $0.19, beating estimates by $0.01, and revenue of $587.30M, which missed estimates by $2.46M and represented a 5.49% year-over-year decrease. The presentation was released in conjunction with their earnings call.
Clarivate Appoints Michael Easton as Chief Financial Officer
Clarivate Plc has announced the appointment of Michael Easton as Executive Vice President and Chief Financial Officer, effective August 8, 2026. Easton, who previously served as Senior Vice President and Chief Accounting Officer, brings over 25 years of financial and operational experience to the role. He succeeds Jonathan Collins and will focus on accelerating growth, improving profitability, and strengthening free cash flow generation for the company.
Clarivate Reports Second Quarter 2026 Results
Clarivate Plc reported its second quarter 2026 results, showing continued progress on its strategic and financial priorities through its Value Creation Plan. The company reaffirmed its full-year 2026 financial outlook, anticipating ACV Organic Growth between 2.0% and 3.0% and Adjusted EBITDA of $980M to $1.04B. Despite a net loss primarily due to a goodwill impairment charge, Clarivate expanded profit margin and reduced debt, maintaining a focus on a more subscription-led revenue base and financial flexibility following the divestiture of its Life Sciences & Healthcare segment.
Clarivate Number of Employees 2026 | Employee Count & Headcount Data
Clarivate Plc (CLVT) had approximately 12,120 employees worldwide as of March 2026, marking a 3.5% growth from 2023 but a 0.8% decline year over year. The company's workforce is primarily concentrated in India, the United States, and Serbia, with an average salary of $54,277 and an average tenure of 4.3 years. Clarivate is actively hiring, though job postings declined by 8.1% in 2026.
Clarivate (NYSE:CLVT) Trading Up 7.3% - Here's What Happened
Clarivate (NYSE:CLVT) shares rose 7.3% in midday trading on Tuesday but traded on significantly reduced volume. Despite beating earnings expectations and some analyst price target increases, the stock maintains a consensus "Reduce" rating from analysts. The company reported a revenue decline year-over-year and remains unprofitable on a net-margin basis.
Clarivate earnings up next: Value plan faces quarterly test By Investing.com
Clarivate (CLVT) is set to report second-quarter earnings, with investors focused on whether its "Value Creation Plan" is improving efficiency despite stagnant revenue. Analysts anticipate earnings of 18 cents per share on $589.7 million in revenue, a 5.1% year-over-year decline. The company's recent sale of its Life Sciences & Healthcare segment and its ability to sustain subscription revenue growth will be key indicators of its transformation efforts.
CLVT|Clarivate PLC|Price:2.146|Chg%:+0.106
Clarivate PLC is a global provider of transformative intelligence in Academia & Government, Intellectual Property, and Life Sciences & Healthcare sectors. The article details its business scope, financial data, and market performance, including its stock symbol (CLVT), current stock price, market capitalization, and key executive shareholders. It also provides insights into the company's revenue streams, noting that Subscription revenues are its biggest source.
Clarivate PLC (CLVT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
Clarivate PLC (CLVT) revenue breakdown reveals that subscription revenues constitute the largest portion at 65.39% ($1.61B), followed by re-occurring revenues at 17.68% ($434.20M). Geographically, the Americas account for over half of the revenue at 53.07% ($1.30B), while Europe/Middle East/Africa and Asia Pacific contribute 26.67% and 20.26% respectively. The data is updated as of April 6 for FY2025 across various quarters, as well as previous fiscal years.
Clarivate (CLVT) Wins AI Contracts, Is The Stock Still Undervalued?
Clarivate (CLVT) has secured significant AI contracts with the U.S. Patent and Trademark Office and France's national academic library system, highlighting its AI capabilities. Despite these wins, the stock has experienced significant price declines, suggesting weakening investor sentiment. Analysts and intrinsic value estimates indicate a potential undervaluation, with a fair value around $4.21 compared to its current price, though revenue contraction and net losses present execution and profitability risks.
Clarivate PLC (CLVT) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides an overview of Clarivate PLC's (CLVT) dividend history and stock splits. It notes that the company has distributed $0.00 in dividends over the past five years, indicating no recent dividend payouts. The article presents a table for dividend dates (Dividend, Record Date, Payment Date, Ex-dividend Date) which currently contains no data.
Clarivate PLC (CLVT) Shareholder Structure: Major Shareholders & Institutional Holdings
This article provides a detailed breakdown of Clarivate PLC's (CLVT) shareholder structure, listing major shareholders, their proportionate holdings, and the types of shareholder entities. It also includes institutional shareholding data over several quarters and details on shareholder activity with changes in holdings for top investors. Additionally, the article lists various ETFs that hold CLVT shares.
Clarivate PLC Revenue Breakdown – HAN:16A
Clarivate PLC (HAN:16A) generated a total revenue of 2.09 billion EUR last year. Its top-performing segment, Academia & Government, contributed 1.08 billion EUR. The United States was the largest regional contributor, accounting for 1.02 billion EUR of the company's revenue.
Price to earnings forward of Clarivate PLC – SWB:16A
This article provides financial information for Clarivate PLC (SWB:16A) on TradingView, specifically focusing on its forward price-to-earnings ratio. It mentions that market data is provided by ICE Data Services and FactSet, and SEC filings by Quartr. The content mainly consists of navigation and boilerplate text from the TradingView platform.
KBC Group NV Makes New Investment in Clarivate PLC $CLVT
KBC Group NV has made a significant new investment in Clarivate PLC (NYSE:CLVT), acquiring over 1.6 million shares valued at $4.1 million in the first quarter of 2026. This move increases institutional ownership in Clarivate, which currently stands at 85.72%. Despite new interest from institutional investors, analyst sentiment remains mixed, with an average rating of "Reduce" and a target price of $2.98 for Clarivate.
Clarivate PLC $CLVT Shares Sold by Clarkston Capital Partners LLC
Clarkston Capital Partners LLC significantly reduced its stake in Clarivate PLC (NYSE:CLVT) by 34.1% during the first quarter, selling over 22 million shares. Despite this, Clarivate remains Clarkston's second-largest holding. Clarivate recently reported better-than-expected quarterly earnings and revenue, though revenue saw a slight year-over-year decrease; however, analysts maintain a cautious "Reduce" rating for the stock.
Earnings Preview: Clarivate to Report Financial Results Pre-market on July 29
Clarivate Plc (NYSE: CLVT) is scheduled to report its financial results before the market opens on July 29, 2026. Analysts currently project the company will announce a quarterly loss of $0.01 per share and revenue of $426.65 million. Investors will be closely watching these figures for insights into Clarivate's financial health.
Clarivate (CLVT) Projected to Announce Earnings on Wednesday
Clarivate (CLVT) is expected to announce its Q2 2026 earnings on Wednesday, July 29th, with analysts projecting $0.17 EPS and $589.7 million in revenue. The company beat expectations in its last quarter, reporting $0.18 EPS, and currently holds a consensus "Reduce" rating from analysts with an average price target of $2.98. Institutional investors have recently modified their holdings, with 85.72% of the stock currently owned by institutions.
ETFs Investing in Clarivate PLC Stocks
This article provides a list of Exchange Traded Funds (ETFs) that hold Clarivate PLC (CLVT) stocks, sorted by market value. It details various ETFs, including their issuers, management styles, expense ratios, assets under management (AUM), and historical performance. The information helps investors identify funds offering exposure to Clarivate PLC, emphasizing the benefits of ETFs for accessibility and risk diversification in stock investing.
Clarivate's trademark AI draws on 172.5M records in 188 jurisdictions
Clarivate's AI-powered trademark risk assessment solution, RiskMark, has received the 2026 CODiE Award for Best AI Tool for Lawyers. Launched in 2025, RiskMark leverages 172.5 million trademark records and over five million decisions to assist legal professionals in evaluating trademark confusion and risk efficiently. The tool combines predictive and generative AI to assess similarity risks, identify conflicts, and produce draft legal arguments, significantly reducing manual research time.
